A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 01, 2021
Source ID
10.1016/j.neuropharm.2021.108599

Entities

People

  • Amanda Moreno
  • Brandon T. Milliken
  • Heath D Schmidt
  • Kael H. Ragnini
  • Kamryn S. Stecyk
  • Matthew R. Hayes
  • Michelle W. Kahng
  • Robert P. Doyle
  • Suditi Rahematpura
  • Yafang Zhang

Organizations

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Drug Abuse
  • United States Department of Defense